Compare ESP & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | ANIK |
|---|---|---|
| Founded | 1928 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 191.4M |
| IPO Year | 1995 | 1996 |
| Metric | ESP | ANIK |
|---|---|---|
| Price | $70.80 | $15.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $64.00 | $17.00 |
| AVG Volume (30 Days) | 15.7K | ★ 107.7K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | 31.88 | ★ 80.16 |
| EPS | ★ 1.75 | N/A |
| Revenue | $43,950,872.00 | ★ $112,819,000.00 |
| Revenue This Year | $10.30 | $5.98 |
| Revenue Next Year | $10.00 | $7.42 |
| P/E Ratio | $40.69 | ★ N/A |
| Revenue Growth | ★ 13.46 | N/A |
| 52 Week Low | $30.00 | $7.90 |
| 52 Week High | $73.50 | $16.24 |
| Indicator | ESP | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 77.59 | 56.77 |
| Support Level | $42.46 | $13.81 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.88 | 0.55 |
| MACD | 1.09 | -0.07 |
| Stochastic Oscillator | 86.03 | 45.61 |
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.